TI
PRVL

Trexquant Investment’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Trexquant Investment’s Portfolio PRVL Stock Details PRVL Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-19,910
Closed -$203K – 1659
2020
Q3 		$203K Buy
+19,910
New +$203K 0.01% 1075